Back
Viking Therapeutics, Inc. Stock Price Chart
Exxon and Chevron Have an Unlikely New Competitor
DISCLOSURE: EnergyX's Regulation A offering has been qualified by the SEC. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available at
Sell
43
VKTX
Viking Therapeutics, Inc.
Last Price:
$31.86
Seasonality Move:
23.23%
7 Day Trial
ALL ACCESS PASS
$
7
The Next Gold Rush
DISCLOSURE: EnergyX's Regulation A offering has been qualified by the SEC. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available at-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VKTX is experiencing slight buying pressure.
Viking Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 32.16 | Buy |
| 20-day SMA: | 34.26 | Buy |
| 50-day SMA: | 35.83 | Sell |
| 200-day SMA: | 30.63 | Buy |
| 8-day EMA: | 32.79 | Buy |
| 20-day EMA: | 33.92 | Buy |
| 50-day EMA: | 34.52 | Sell |
| 200-day EMA: | 33.94 | Buy |
Viking Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.04 | Sell |
| Relative Strength Index (14 RSI): | 50.18 | Buy |
| Chaikin Money Flow: | 2683780 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (32.72 - 36.92) | Sell |
| Bollinger Bands (100): | (27.86 - 37.28) | Buy |
Viking Therapeutics, Inc. Technical Analysis
| Dec 31 | Jan 2 | Jan 5 | Jan 6 | Jan 7 | Jan 8 | Jan 9 | Jan 12 | Jan 13 | Jan 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 31 | 02 | 05 | 06 | 07 | 08 | 09 | 12 | 13 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Viking Therapeutics, Inc. Stock
Is Viking Therapeutics, Inc. Stock a Buy?
-
Viking Therapeutics, Inc. share price is 34.34 while VKTX 8-day simple moving average is 32.16, which is a Buy signal.
-
The stock price of VKTX is 34.34 while Viking Therapeutics, Inc. 20-day SMA is 34.26, which makes it a Buy.
-
Viking Therapeutics, Inc. 50-day simple moving average is 35.83 while VKTX share price is 34.34, making it a Sell technically.
-
VKTX stock price is 34.34 and Viking Therapeutics, Inc. 200-day simple moving average is 30.63, creating a Buy signal.
VKTX Technical Analysis vs Fundamental Analysis
Sell
43
Viking Therapeutics, Inc. (VKTX)
is a Sell
Is Viking Therapeutics, Inc. a Buy or a Sell?
-
Viking Therapeutics, Inc. stock is rated a SellThe current Viking Therapeutics, Inc. [VKTX] share price is $34.34. The Score for VKTX is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
Viking Therapeutics, Inc. Stock Info
Market Cap:
3.9B
Price in USD:
34.34
Share Volume:
6.9M
Viking Therapeutics, Inc. 52-Week Range
52-Week High:
43.15
52-Week Low:
18.92
Sell
43
Viking Therapeutics, Inc. (VKTX)
is a Sell
Viking Therapeutics, Inc. Share Price Forecast
-
What is the Viking Therapeutics, Inc. stock price today?The Viking Therapeutics, Inc. stock price is 34.34 USD today.
-
Will VKTX stock go up or go down?Viking Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Viking Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Viking Therapeutics, Inc. is overvalued.
Is Viking Therapeutics, Inc. Stock a Buy?
-
Viking Therapeutics, Inc. share price is 34.34 while VKTX 8-day exponential moving average is 32.79, which is a Buy signal.
-
The stock price of VKTX is 34.34 while Viking Therapeutics, Inc. 20-day EMA is 33.92, which makes it a Buy.
-
Viking Therapeutics, Inc. 50-day exponential moving average is 34.52 while VKTX share price is 34.34, making it a Sell technically.
-
VKTX stock price is 34.34 and Viking Therapeutics, Inc. 200-day simple moving average is 33.94, creating a Buy signal.
Fundamental Analysis of Viking Therapeutics, Inc.
Is Viking Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.34 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.11 per share, and a decrease next year of $0.28 per share.
Technical Analysis of Viking Therapeutics, Inc.
Should I short Viking Therapeutics, Inc. stock?
-
VKTX Moving Average Covergence Divergence (MACD) indicator is -1.04, suggesting Viking Therapeutics, Inc. is a Sell
-
Viking Therapeutics, Inc. Relative Strength Index (RSI) is 50.18, which suggest Viking Therapeutics, Inc. is overbought
-
The Bollinger Bands (25) for Viking Therapeutics, Inc. is (32.72 - 36.92), which suggest Viking Therapeutics, Inc. is a Buy
-
The Bollinger Bands (100) for Viking Therapeutics, Inc. is (27.86 - 37.28), which suggest Viking Therapeutics, Inc. is a Buy
* Viking Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.